A Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
This study represents the first administration of GSK376501 in humans and the goal is to
evaluate its initial safety and tolerability. The way the human body processes GSK376501 will
also be determined.